Agios Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
04.06.24
/
50%
€42.20
Target price
04.06.25
€48.75
Performance (%)
-2.37%
Price
22.08.24
€41.20
Summary
This prediction is currently active. With a performance of -2.37%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 04.06.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Agios Pharmaceuticals Inc. | 0.000% | 0.000% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target raised by analysts at Royal Bank of Canada from $44.00 to $53.00. They now have an "outperform" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€40.40
02.08.24
02.08.24
€50.39
02.08.25
02.08.25
1.98%
22.08.24
22.08.24
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€24.80
16.02.24
16.02.24
€38.99
16.02.25
16.02.25
66.13%
22.08.24
22.08.24